» Articles » PMID: 21908193

Structural Requirement of Arylindolylpropenones As Anti-bladder Carcinoma Cells Agents

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2011 Sep 13
PMID 21908193
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Chalcones have been identified as interesting compounds with cytotoxicity, anti-inflammatory and antioxidant properties. In the present study, we report the synthesis and evaluation of new 1-(N-methylindolyl)-3-phenylpropenones as anti-cancer agents acting on bladder carcinoma cell line. Among the 15 investigated molecules, three of them inhibit the growth of bladder cancer cells with IC(50) values less than 4 μM after 48 h of treatment. To investigate their mode of action, cell cycle analyses were performed. The most active compounds induce high accumulation at the G2+M phase as assessed by flow cytometry. The structure-activity relationship drawn from the present study highlights the importance of the substitution pattern of the phenyl ring and provides valuable information for further development of this class of compounds as novel anti-cancer chemotherapeutic agents.

Citing Articles

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth and patient-derived xenografts .

Yin F, Zhao R, Gorja D, Fu X, Lu N, Huang H Acta Pharm Sin B. 2022; 12(11):4122-4137.

PMID: 36386480 PMC: 9643289. DOI: 10.1016/j.apsb.2022.07.005.


Synthesis and Inhibitory Effect of Some Indole-Pyrimidine Based Hybrid Heterocycles on α-Glucosidase and α-Amylase as Potential Hypoglycemic Agents.

Badria F, Atef S, Al-Majid A, Ali M, Elshaier Y, Ghabbour H ChemistryOpen. 2019; 8(10):1288-1297.

PMID: 31649838 PMC: 6804419. DOI: 10.1002/open.201900240.


6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.

Du S, Sarver J, Trabbic C, Erhardt P, Schroering A, Maltese W Cancer Chemother Pharmacol. 2018; 83(2):237-254.

PMID: 30426158 PMC: 6645365. DOI: 10.1007/s00280-018-3726-1.


IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma.

Martel-Frachet V, Keramidas M, Nurisso A, DeBonis S, Rome C, Coll J Oncotarget. 2015; 6(16):14669-86.

PMID: 26036640 PMC: 4546496. DOI: 10.18632/oncotarget.4144.


Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity.

Trabbic C, Overmeyer J, Alexander E, Crissman E, Kvale H, Smith M J Med Chem. 2015; 58(5):2489-512.

PMID: 25654321 PMC: 4360382. DOI: 10.1021/jm501997q.